Company: CMND
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112329
Chunk: 16

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 16
---
 offering, as of November 18, 2025.
This sale and any future sales of a substantial number of Common Shares in the public market, or the perception that such sales may occur,
could materially adversely affect the price of our Common Shares. We cannot predict the effect, if any, that market sales of those Common
Shares or the availability of those Common Shares for sale will have on the market price of our Common Shares.

We do not know whether a market for the Common Shares will be sustained or what the trading price of the Common Shares will be and as a result it may be difficult for you to sell your Common Shares.

Although our Common Shares
trade on the Nasdaq and the FSE, an active trading market for the Common Shares may not be sustained. It may be difficult for you to sell
your Common Shares without depressing the market price for the Common Shares. As a result of these and other factors, you may not be able
to sell your Common Shares. Further, an inactive market may also impair our ability to raise capital by selling Common Shares and may
impair our ability to enter into strategic partnerships or acquire companies or products by using our Common Shares as consideration.

Part of our operations are conducted in Israel. Conditions in Israel, including the recent attack by Hamas and other terrorist organizations and Israel’s war against them, may affect our operations.

Our operations are located
in the State of Israel. In addition, certain of our key employees and officers, including our chief executive officer, are residents of
Israel. Accordingly, political, economic and military conditions in the Middle East may affect our business directly. Since the establishment
of the State of Israel in 1948, a number of armed conflicts have occurred between Israel and its neighboring countries and terrorist organizations
active in the region, including Hamas (an Islamist militia and political group in the Gaza Strip) and Hezbollah (an Islamist militia and
political group in Lebanon).

In October 2023, Hamas terrorists
infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas
also launched extensive rocket attacks on Israeli population and industrial centers located along Israel’s border with the Gaza
Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians
and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and a military campaign against these
terrorist organizations commenced in parallel to their continued rocket and terror attacks. In January 2025, Israel